Raheela Ashfaq
Papers
1
Total Citations
33
H-Index
1
About
Dr. Raheela Ashfaq is a distinguished molecular pathologist whose pioneering work has significantly advanced the field of epigenetic biomarkers, particularly in cancer diagnostics. Her research focuses on DNA methylation patterns as diagnostic and prognostic tools, with a landmark contribution being the establishment and validation of a real-time polymerase chain reaction method for detecting CDH1 promoter methylation. This seminal 2002 study, which has garnered 33 citations, provided a robust, quantitative framework for analyzing gene silencing in tumors, directly impacting the early detection and risk stratification of cancers such as gastric and breast malignancies. Dr. Ashfaq’s methodological innovations have enabled more precise and reproducible methylation assays, bridging the gap between laboratory research and clinical application. Her work is widely recognized for its technical rigor and translational relevance, influencing subsequent studies on epigenetic silencing in oncology. Through her dedication to refining molecular techniques, Dr. Ashfaq has empowered researchers and clinicians to better understand the role of methylation in cancer progression, solidifying her reputation as a key figure in the evolution of personalized medicine.
Research Focus
Key Achievements
Top Papers
- 1